General MedicationsORALStandard
THEOPHYLLINE
THEOPHYLLINE
Standard Dose
600MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview THEOPHYLLINE is listed in Drugs@FDA under application 090355 (ANDA).
Marketing status: Prescription Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 600MG Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2010-07-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview THEOPHYLLINE is listed in Drugs@FDA under application 090355 (ANDA). Marketing status: Prescription Active ingredient THEOPHYLLINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 600MG Sponsor GLENMARK PHARMS LTD Submission history Latest submission status date: 2010-07-13 00:00:00. Submission type: ORIG.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.